Sorrento secures Brazil clearance to start Phase IIa long Covid trial
The trial will assess the safety and efficacy of up to three intravenous doses of COVI-MSC administered on alternate days.
Vishnu Priyan
Latest articles
All Articles
Sciwind commences dosing in Phase IIb obesity drug trial
The trial will be carried out in Australia and New Zealand, and will enrol nearly 200 patients with obesity.
George Medicines to analyse three-in-one hypertension pill in UK trial
The trial will assess the efficacy and safety of GMRx2 against dual cocktails of the same components for 12…
HDT Bio dose first subjects in Phase I Covid-19 vaccine trial
The trial will enrol 90 subjects to assess the safety, tolerability, and immunogenicity of three dose levels of the…
Bod Australia to start long Covid-19 trial using medicinal cannabis in UK
The trial intends to enrol up to 30 subjects who are aged over 18 years with long Covid-19.
Algernon receives positive FDA feedback on Phase IIb chronic cough trial
The pre-IND meeting guided the company on the Phase IIb protocol design and selection of trial endpoints.
Numinus seeks Health Canada approval to start psychedelic product trial
The autonomous, two-phased trial HOPE will be conducted at a Numinus clinic in Vancouver, Canada.
Pieris doses first subject in Phase II gastric cancer drug trial
Cinrebafusp alfa had acceptable safety profile at all dose levels tested without any dose-limiting toxicities in Phase I trials.
Ascletis doses first participant in Phase II acne oral therapy trial
The trial will evaluate the safety and efficacy of ASC40 to treat individuals with moderate to severe acne in…